Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
URI Capital Management
Hong Kong, Hong Kong
- Ownership
- Private
- Development stage
- Other
01
Overview
URI Capital Management is a Hong Kong-based asset management firm that specializes in the healthcare and life sciences sectors, with a primary focus on the Greater China region. The firm manages private equity and venture capital investments, targeting growth-stage companies across biotechnology, medical devices, and healthcare services. URI Capital Management leverages deep industry expertise and a localized network to identify innovative healthcare solutions that address significant unmet medical needs. Its portfolio includes several prominent Chinese biopharmaceutical companies, reflecting its strategic role in supporting the expansion of the Asian healthcare ecosystem.
- Industry
- Investors
Beyond the preview
Go deeper on URI Capital Management.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on URI Capital Management.